Search Results - "Janne, P P"

Arctic narratives: brewing a brand with neolocalism by Ikäheimo, Janne P.

“…Neolocalism has been identified as an important component in the current boom in microbreweries. When constructed actively and consciously, it can also be…”
Get full text

CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials by Goss, G., Tsai, C.-M., Shepherd, F.A., Ahn, M.-J., Bazhenova, L., Crinò, L., de Marinis, F., Felip, E., Morabito, A., Hodge, R., Cantarini, M., Johnson, M., Mitsudomi, T., Jänne, P.A., Yang, J.C.-H.

“…Central nervous system (CNS) metastases are common in patients with non-small-cell lung cancer (NSCLC). Osimertinib has shown systemic efficacy in patients…”
Get full text

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer by Passaro, A., Leighl, N., Blackhall, F., Popat, S., Kerr, K., Ahn, M.J., Arcila, M.E., Arrieta, O., Planchard, D., de Marinis, F., Dingemans, A.M., Dziadziuszko, R., Faivre-Finn, C., Feldman, J., Felip, E., Curigliano, G., Herbst, R., Jänne, P.A., John, T., Mitsudomi, T., Mok, T., Normanno, N., Paz-Ares, L., Ramalingam, S., Sequist, L., Vansteenkiste, J., Wistuba, I.I., Wolf, J., Wu, Y.L., Yang, S.R., Yang, J.C.H., Yatabe, Y., Pentheroudakis, G., Peters, S.

“…The European Society for Medical Oncology (ESMO) held a virtual consensus-building process on epidermal growth factor receptor (EGFR)-mutant non-small-cell…”
Get full text

MET increased gene copy number and primary resistance to gefitinib therapy in non-small-cell lung cancer patients by Cappuzzo, F., Jänne, P. A., Skokan, M., Finocchiaro, G., Rossi, E., Ligorio, C., Zucali, P. A., Terracciano, L., Toschi, L., Roncalli, M., Destro, A., Incarbone, M., Alloisio, M., Santoro, A., Varella-Garcia, M.

“…Background: MET amplification has been detected in ∼20% of non-small-cell lung cancer patients (NSCLC) with epidermal growth factor receptor (EGFR) mutations…”
Get full text

Predistortion-Based Linearization for 5G and Beyond Millimeter-Wave Transceiver Systems: A Comprehensive Survey by Haider, Muhammad Furqan, You, Fei, He, Songbai, Rahkonen, Timo, Aikio, Janne P.

“…The next-generation (5G/6G) wireless communication aims to leapfrog the currently occupied sub-6 GHz spectrum to the wideband millimeter-wave (MMW) spectrum…”
Get full text

Analysis and Design of Capacitive Voltage Distribution Stacked MOS Millimeter-Wave Power Amplifiers by Montaseri, Mohammad Hassan, Aikio, Janne P., Rahkonen, Timo, Parssinen, Aarno

“…Stacked MOS power amplifiers (PA) are commonly used in SOI nodes but also have the potential to be realized in bulk CMOS nodes. In this paper they are analyzed…”
Get full text

Trust and distrust in interorganizational networks - the case of Norwegian child welfare and protection by Lo, Christian, Breimo, Janne P., Turba, Hannu

“…Trust remains one of the most frequently recurring concepts in the literature about interorganizational networks. The present paper combines different…”
Get full text

Digital Predistortion of Phased-Array Transmitter With Shared Feedback and Far-Field Calibration by Tervo, Nuutti, Khan, Bilal, Kursu, Olli, Aikio, Janne P., Jokinen, Markku, Leinonen, Marko E., Juntti, Markku, Rahkonen, Timo, Parssinen, Aarno

“…Digital predistortion (DPD) of a phased array requires that multiple transmit paths must be measured by a feedback (FB) receiver (Rx). In this article, we…”
Get full text

Combined Sidelobe Reduction and Omnidirectional Linearization of Phased Array by Using Tapered Power Amplifier Biasing and Digital Predistortion by Tervo, Nuutti, Khan, Bilal, Aikio, Janne P., Kursu, Olli, Jokinen, Markku, Leinonen, Marko E., Sonkki, Marko, Rahkonen, Timo, Parssinen, Aarno

“…Power amplifier (PA) efficiency and linearity are among the key drivers to reduce energy consumption while enabling high data rates in the fifth-generation…”
Get full text

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: results from the Actionable Genome Consortium by Li, B.T., Janku, F., Jung, B., Hou, C., Madwani, K., Alden, R., Razavi, P., Reis-Filho, J.S., Shen, R., Isbell, J.M., Blocker, A.W., Eattock, N., Gnerre, S., Satya, R.V., Xu, H., Zhao, C., Hall, M.P., Hu, Y., Sehnert, A.J., Brown, D., Ladanyi, M., Rudin, C.M., Hunkapiller, N., Feeney, N., Mills, G.B., Paweletz, C.P., Janne, P.A., Solit, D.B., Riely, G.J., Aravanis, A., Oxnard, G.R.

“…Noninvasive genotyping using plasma cell-free DNA (cfDNA) has the potential to obviate the need for some invasive biopsies in cancer patients while also…”
Get full text

Chip-to-Chip Interfaces for Large-Scale Highly Configurable mmWave Phased Arrays by Sethi, Alok, Akbar, Rehman, Hietanen, Mikko, Aikio, Janne P., Kursu, Olli, Jokinen, Markku, Leinonen, Marko E., Rahkonen, Timo, Parssinen, Aarno

“…This article presents a chip-to-chip (C2C) interface for constructing reconfigurable phased arrays to be used in fifth-generation (5G)/sixth-generation (6G)…”
Get full text

Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study by Thiele, Liv S, Ishtiak-Ahmed, Kazi, Thirstrup, Janne P, Agerbo, Esben, Lunenburg, Carin A T C, Müller, Daniel J, Gasse, Christiane

“…Background: The clinical impact of the functional CYP2C19 and CYP2D6 gene variants on antidepressant treatment in people with depression is not well studied…”
Get full text

Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells by Wang, J, Mikse, O, Liao, R G, Li, Y, Tan, L, Janne, P A, Gray, N S, Wong, K-k, Hammerman, P S

“…Somatic alterations of fibroblast growth factor receptors (FGFRs) have been described in a wide range of malignancies. A number of anti-FGFR therapies are…”
Get full text

Exploring the Genetic Risk of Childhood Daytime Urinary Incontinence: A Genome-Wide Association Study by Breinbjerg, Anders, Jørgensen, Cecilie Siggaard, Walters, G. Bragi, Grove, Jakob, Als, Thomas D., Kamperis, Konstantinos, Stéfansdóttir, Lilja, Thirstrup, Janne P., Borg, Britt, Albiñana, Clara, Vilhjálmsson, Bjarni J., Eðvarðsson, Viðar Ö., Stefánsson, Hreinn, Mortensen, Preben B., Agerbo, Esben, Werge, Thomas, Børglum, Anders, Demontis, Ditte, Stefánsson, Kári, Rittig, Søren, Christensen, Jane Hvarregaard

“…Childhood incontinence is stigmatized and underprioritized, and a basic understanding of its pathogenesis is missing. Our goal was to identify risk-conferring…”
Get full text

Commercial arc fault detection devices in military electromagnetic environment by Pulkkinen, Janne P.

“…Arc fault detection device (AFDD) is the latest protection device for low voltage circuits. It is used to detect arcing faults that cannot be detected by…”
Get full text

Decline in the Cumulative Incidence of Severe Diabetic Retinopathy in Patients With Type 1 Diabetes by KYTO, Janne P, HARJUTSALO, Valma, FORSBLOM, Carol, HIETALA, Kustaa, SUMMANEN, Paula A, GROOP, Per-Henrik

“…To determine if the cumulative incidence of severe retinopathy in patients with type 1 diabetes has changed. The study looked at 3,781 patients diagnosed with…”
Get full text

Osimertinib plus platinum–pemetrexed in newly diagnosed epidermal growth factor receptor mutation-positive advanced/metastatic non-small-cell lung cancer: safety run-in results from the FLAURA2 study by Planchard, D., Feng, P.-H., Karaseva, N., Kim, S.-W., Kim, T.M., Lee, C.K., Poltoratskiy, A., Yanagitani, N., Marshall, R., Huang, X., Howarth, P., Jänne, P.A., Kobayashi, K.

“…The phase III FLAURA2 (NCT04035486) study will evaluate efficacy and safety of first-line osimertinib with platinum–pemetrexed chemotherapy versus osimertinib…”
Get full text

Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG Partners Foundation by Peters, S, Loi, S, André, F, Chandarlapaty, S, Felip, E, Finn, S P, Jänne, P A, Kerr, K M, Munzone, E, Passaro, A, Pérol, M, Smit, E F, Swanton, C, Viale, G, Stahel, R A

“…Following the approval of the first antibody-drug conjugates (ADCs) in the early 2000s, development has increased dramatically, with 14 ADCs now approved and…”
Get more information

The aftermath of the Covid-19 crisis in the field of intimacy: How to bounce back and rethink our values? by Duray-Parmentier, C, Nielens, N, Duray, D, Janne, P, Gourdin, M

“…Human relationships and bonding reconfigure and reinvent themselves over time. For several decades, it has been interesting to note that both the digital…”
Get more information

Distribution and characteristics of occupational injuries and diseases among farmers: A retrospective analysis of workers' compensation claims by Karttunen, Janne P., Rautiainen, Risto H.

“…Background Research indicates occupational injuries and diseases are not evenly distributed among workers. We investigated the distribution and characteristics…”
Get full text